Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Getting peptide vaccines to work: just a matter of quality control?

× No keyword cloud information.

26 in total

1. Serum proteases alter the antigenicity of peptides presented by class I major histocompatibility complex molecules.

Authors: L D Falo; L J Colarusso; B Benacerraf; K L Rock
Journal: Proc Natl Acad Sci U S A Date: 1992-09-01 Impact factor: 11.205

Review 2. Dominance and crypticity of T cell antigenic determinants.

Authors: E E Sercarz; P V Lehmann; A Ametani; G Benichou; A Miller; K Moudgil
Journal: Annu Rev Immunol Date: 1993 Impact factor: 28.527

3. Synthetic peptides as vaccines.

Authors: J Rothbard
Journal: Nature Date: 1987 Nov 12-18 Impact factor: 49.962

4. Designing peptide vaccines to broaden recognition and enhance potency.

Authors: J A Berzofsky
Journal: Ann N Y Acad Sci Date: 1995-05-31 Impact factor: 5.691

5. Analysis of the fine specificity of rat, mouse and human TAP peptide transporters.

Authors: J Neefjes; E Gottfried; J Roelse; M Grommé; R Obst; G J Hämmerling; F Momburg
Journal: Eur J Immunol Date: 1995-04 Impact factor: 5.532

6. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

Authors: K C Parker; M A Bednarek; J E Coligan
Journal: J Immunol Date: 1994-01-01 Impact factor: 5.422

7. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides.

Authors: D Kyburz; P Aichele; D E Speiser; H Hengartner; R M Zinkernagel; H Pircher
Journal: Eur J Immunol Date: 1993-08 Impact factor: 5.532

8. Trimming of antigenic peptides in an early secretory compartment.

Authors: H L Snyder; J W Yewdell; J R Bennink
Journal: J Exp Med Date: 1994-12-01 Impact factor: 14.307

9. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.

Authors: F R Carbone; M J Bevan
Journal: J Exp Med Date: 1990-02-01 Impact factor: 14.307

10. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.

Authors: F Sallusto; M Cella; C Danieli; A Lanzavecchia
Journal: J Exp Med Date: 1995-08-01 Impact factor: 14.307

5 in total

1. High-yield expression of isotopically labeled peptides for use in NMR studies.

Authors: Darrin A Lindhout; Angela Thiessen; Dean Schieve; Brian D Sykes
Journal: Protein Sci Date: 2003-08 Impact factor: 6.725

2. Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35.

Authors: Arvind Chhabra; Nitya G Chakraborty; Bijay Mukherji
Journal: Clin Immunol Date: 2008-01-14 Impact factor: 3.969

Review 3. Immunity against soft-tissue sarcomas.

Authors: Robert G Maki
Journal: Curr Oncol Rep Date: 2003-07 Impact factor: 5.075

Review 4. Active antigen-specific immunotherapy of melanoma: from basic science to clinical investigation.

Authors: Giulio C Spagnoli; Michel Adamina; Martin Bolli; Walter P Weber; Paul Zajac; Walter Marti; Daniel Oertli; Michael Heberer; Felix Harder
Journal: World J Surg Date: 2005-06 Impact factor: 3.282

Review 5. Computer-Assisted and Data Driven Approaches for Surveillance, Drug Discovery, and Vaccine Design for the Zika Virus.

Authors: Subhash C Basak; Subhabrata Majumdar; Ashesh Nandy; Proyasha Roy; Tathagata Dutta; Marjan Vracko; Apurba K Bhattacharjee
Journal: Pharmaceuticals (Basel) Date: 2019-10-16

5 in total